Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nebulized Dexmedetomidine on Central Sensitization and Chronification in Migraine
NCT07769255Recruiting
- Sponsor
- Beni Suef University
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised trial in chronic migraine comparing Group A (Nebulized dexmedetomidine) with Group B (Placebo) (2 arms). Primary endpoint: Treatment of Chronic Migraine at 6 months. Started Sep 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT07769255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769255.